Regeneron Pharmaceuticals, Inc.
ANTI-CD63 ANTIBODIES, CONJUGATES, AND USES THEREOF

Last updated:

Abstract:

Antibodies, portions, and fusion proteins thereof to CD63 are provided. Also provided are nucleic acid sequences encoding same. Also provided are compositions comprising and methods of using same, e.g., for treating a patient in need thereof.

Status:
Application
Type:

Utility

Filling date:

17 May 2019

Issue date:

18 Mar 2021